Covishield maker SII seeks indemnity from liability : vimars

Covishield maker SII seeks indemnity from liability


Covishield maker SII seeks indemnity from liability
Covishield maker SII seeks indemnity from liability
IANS / Updated: Jun 4, 2021, 09:06 IST
#NEWDELHI Pune-based Serum Institute of India (SII), which manufactures
Covishield, has also sought indemnity from liability, expressing the hope that rules would be the same for everyone, said sources. This comes as the Centre is favourably considering granting indemnity against legal proceedings to foreign vaccine makers Pfizer and Moderna prior to their rollout in India.
“All vaccine makers, whether Indian or foreign, should be granted the same protection,” the Adar Poonawalla-led company has reportedly told the government.
“Not just Serum Institute of India (SII), all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted it,” it further said. It is learnt that Serum is hoping that rules should be same for everyone. The Serum Institute produces Covishield (the Indian name for the

Related Keywords

India , Russia , United Kingdom , Russian , Oxford Astrazeneca Covishield , Novovax Covovax , Pfizer , Serum Institute , Serum Institute Of India , Adar Poonawalla Led , Drug Controller General , Emergency Use Authorisation , Serum Institute Of India Sii , Russian Sputnikv Covid 19 Vaccine , Foreign Vaccine Pfizer , Emergency Use Authorisation Eua , Covishield , Astrazeneca Oxford Jab , Anti Covid Vaccines , இந்தியா , ரஷ்யா , ஒன்றுபட்டது கிஂக்டம் , ரஷ்ய , ஃபைசர் , சீரம் நிறுவனம் , சீரம் நிறுவனம் ஆஃப் இந்தியா , அடார் பூனாவல்ல வழிநடத்தியது , மருந்து கட்டுப்படுத்தி ஜநரல் , சீரம் நிறுவனம் ஆஃப் இந்தியா ஸ் ,

© 2025 Vimarsana